Furthermore, during myocardial remodeling processes, ubiquitination-mediated degradation of poly (ADP-ribose) polymerase 1 (PARP-1) was found to attenuate apoptotic damage, thereby alleviating pathological cardiac hypertrophy and heart failure development (Zhang et al., 2020). Here, PARP1 is linked to cardiac hypertrophy.